Coral Oghenerukevwe Omene, M.D., PH.D
Medical Oncology Physician · New York, NY
Coral Oghenerukevwe Omene, M.D., PH.D is a medical oncology physician with a practice address in New York, New York, and NPI 1861688988, issued on Sep 21, 2007. Check the license (New York 237056, as entered in NPPES) on the NYS Education Department, Office of the Professions; the Medicare figures below come from public CMS files.
- Name
- Coral Oghenerukevwe Omene
- Credential
- M.D., PH.D
- Primary taxonomy
- Medical Oncology Physician 207RX0202X
- License numbers
- 237056 NY
25MA10050600 NJ
Self-reported in NPPES; status is on the state search - Practice location
- 550 1St Ave Bldg CD, New York, NY 10016
- Phone
- (212) 263-6485
- Enumerated
- Sep 21, 2007
- Record last updated
- May 3, 2024
- Medicare enrollment
- Enrolled (PECOS I20170615000100); accepts Medicare assignment
- Medical or professional school
- Columbia University College Of Physicians And Surgeons, 2003
- Entity
- Type 1 · individual
8 nearest medical oncology physician records → All 548 in New York → Look up another NPI →
Verify Coral Oghenerukevwe Omene in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersNYS Education Department, Office of the Professions
Search for license 237056Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
55% fewer Medicare Part D claims than the average medical oncology physician in 2024
316 Medicare Part D claims for 99 beneficiaries, against an average of 703 among the 4,230 providers of this specialty who prescribed in Part D. Brand-name drugs were 19% of claims.
Most prescribed
- Letrozole111 claims
- Tamoxifen Citrate40 claims
- Ibrance21 claims
- Verzenio21 claims
- Alendronate Sodium18 claims
- Exemestane14 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $2,740.00
1 payment: consulting fee; the largest payer was AstraZeneca Pharmaceuticals LP. The 3,343 providers of this specialty with any payment received $11,773.47 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Rutgers Health-Rwj Scleroderma ProgramNew Brunswick, NJ
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Coral Oghenerukevwe Omene among 548 medical oncology physician records in New York
Coral Oghenerukevwe Omene, M.D., PH.D is one of 548 medical oncology physician records with a practice address in New York. 80% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2007, is newer than 40% of them.
- NPI issued2007 · 40% of these records are older, 53% newer
- In a Medicare fileYes · 80% of these records are
- In the CMS Doctors and Clinicians fileYes · 71% of these records are
- Graduated2003 · median 2005 among the 389 with a school on file
- Record last updated2024 · 60% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RX0202X and a New York practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Medical Oncology Physician providers in New York
There are 548 medical oncology physician records in New York.
All 548 in New York → Every provider in New York → Medical Oncology Physician nationwide →
The 8 medical oncology physician records with the nearest ZIP codes
- Marc Ballas, M.D., M.P.H.New York, NY 100161952527269
- Nancy Chan, MDNew York, NY 100161275860892
- Daniel Cho, M.D.New York, NY 100161750306783
- Francisco Esteva, M.D., PHDNew York, NY 100161609974245
- Robert Ilaria, M.D.New York, NY 100161720177934
- Arjun Iyengar, M.DNew York, NY 100161053603340
- Janice MehnertNew York, NY 100161962617472
- Ruth Oratz, MDNew York, NY 100161275625592
Common questions
What is Coral Oghenerukevwe Omene, M.D., PH.D's NPI number?
Coral Oghenerukevwe Omene, M.D., PH.D's National Provider Identifier (NPI) is 1861688988, issued on Sep 21, 2007. An NPI identifies a provider in billing; it is not a license.
Where is Coral Oghenerukevwe Omene, M.D., PH.D located?
The NPPES record lists a practice address at 550 1St Ave Bldg CD, New York, NY, 10016. Phone: (212) 263-6485. Providers update this record themselves, so call before visiting.
How can I verify Coral Oghenerukevwe Omene, M.D., PH.D's license?
NPPES lists New York license number 237056, as entered by the provider. Search the NYS Education Department, Office of the Professions at https://www.op.nysed.gov/services/verifications/online-verification-searches. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Coral Oghenerukevwe Omene, M.D., PH.D prescribe under Medicare Part D?
In 2024, Coral Oghenerukevwe Omene, M.D., PH.D had 316 Medicare Part D claims for 99 beneficiaries; the average among medical oncology physician prescribers was 703. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.